A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic tissue and 3D bioprinting technology. This study was recently published ...

Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Precancerous pancreatic lesions and some pancreatic ductal adenocarcinoma (PDAC) tumors harboring KRAS mutations had ...

Tonelli and Tuveson observed this outcome in mice and organoids—lab-grown versions of human pancreatic tissue. Of course, the researchers weren’t just having a look. Their goal was to stop the ...

By analyzing murine and human pancreatic tissue specimens, Tonelli and colleagues found that compared with normal tissue, FGFR2 expression was higher in KRAS-mutated precancerous lesions and some ...

People with chronic pancreatitis can have permanent damage to their pancreas and other complications. Scar tissue develops from this continuing inflammation. Pancreatitis can damage cells that ...

Actuate Therapeutics' elraglusib shows promise for pancreatic cancer, but financial instability and risks make it a high-risk ...

Optimizing gelatin hydrogels for volumetric 3D bioprinting. Insights from Rousselot’s Jos Olijve on the ENLIGHT bioprinting project.